Recently, consumer articles heralded that blood tests for detecting Alzheimer’s dementia (AD) and many cancers were close to clinical availability. Given the narrow window in which AD must be diagnosed for present treatments to be effective, and questions regarding the utility of early cancer detection, will these tests provide any patient advantage? Presently, there are
Are new blood tests for Alzheimer’s and cancer worth the hype? originally appeared in KevinMD.com.
